Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin

Fundamental and Applied Toxicology

Volumn 32, Issue 2, 1996, Pages 285-292

  Dostal, Lori A ^a   Whitfield, Lloyd R ^a   Anderson, John A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; FEMALE; FERTILITY; FOOD INTAKE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGAN WEIGHT; RAT; REPRODUCTION; WEIGHT GAIN;

ANIMALIA;

EID: 85033071055     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0132     Document Type: Article

References (30)

1. Alberts, A. W., MacDonald, J. S., Till, A. E., and Tobert, J. A. (1989). Lovastatin. Cardiovasc. Drug Rev. 7, 89-109.
2. Blazak, W. F., Rushbrook, C. J., Ernst, T. L., Stewart, B. E., Spak, D., DiBiasio-Erwin, D., and Black, V. (1985). Relationship between breeding performance and testicular/epididymal functioning in male Sprague-Dawley rats exposed to nitrobenzene. Toxicologist 5, 121.
3. Blazak, W. F., Treinen, K. A., and Juniewicz, P. E. (1993). Application of testicular sperm head counts in the assessment of male reproductive toxicity. In Methods in Toxicology: Male Reproductive Toxicology (R. E. Chapin and J. J. Heindel, Eds.), Vol. 3, Part A, pp. 86-94. Academic Press, San Diego.
4. Dobs, A. S., Sarma, P. S., and Schteingart, D. (1993). Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Metabolism 42, 1146-1152.
5. Dostal, L. A., Schardein, J. L., and Anderson, J. A. (1994). Developmental toxicity of the HMG-CoA reductase inhibitor, atorvastatin, in rats and rabbits. Teratology 50, 387-394.
6. Dostal, L. A., Faber, C. K., Rothwell, C. E., and Anderson, J. A. (1995). Semen analysis and sperm counts in beagle dogs treated with the HMG-CoA reductase inhibitor, atorvastatin. Toxicologist 15, 248.
7. Endo, A., Tsujita, Y., Kuroda, M., and Tanzawa, K. (1979). Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals. Biochim. Biophys. Acta 575, 266-276.
8. Farnsworth, W. H., Hoeg, J. M., Maher, M., Brittain, E. H., Sherins, R. J., and Brewer, H. B., Jr. (1987). Testicular function in Type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin. J. Clin. Endocrinol. Metab. 65, 546-550.
9. FDA (1987). Summary basis for approval of NDA 19-643 (lovastatin), p. 13.
10. FDA (1993). Summary basis for approval of NDA 20-261 (fluvastatin), Pharmacology Review of Amendment Conducted August, 1988.
11. Frishman, W. H., Zimetbaum, P., and Nadelmann, J. (1989). Lovastatin and other HMG-CoA reductase inhibitors. J. Clin. Pharmacol. 29, 975-982.
12. Gerson, R. J., MacDonald, J. S., Alberts, A. W., Kornbrust, D. J., Majka, J. A., Stubbs, R. J., and Bokelman, D. L. (1989). Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors. Am. J. Med. 87(Suppl. 4A), 28S-38S.
13. Gibaldi, M., and Perrier, D. (1982). Pharmacokinetics, 2nd ed., Dekker, New York.
14. ICH (1994). International conference on harmonisation: Guideline on detection of toxicity to reproduction for medicinal products. Fed. Reg. 59(183), 22, 48746-48752.
15. Krause, B. R., and Newton, R. S. (1995). Lipid-lowering activity of atorvastatin and lovastatin in rodent species: Triglyceride-lowering in rats correlates with efficacy in LDL animal models. Atherosclerosis 117, 237-244.
16. MacDonald, J. S., Gerson, R. J., Kornbrust, D. J., Kloss, M. W., Prahalada, S., Berry, P. H., Alberts, A. W., and Bokelman, D. L. (1988). Preclinical evaluation of lovastatin. Am. J. Cardiol. 62, 16J-27J.
17. Meistrich, M. L. (1982). Quantitative correlation between testicular stem cell survival, sperm production and fertilization in mouse after treatment with different cytotoxic agents. J. Androl. 3, 58-68.
18. Minsker, D. H., MacDonald, J. S., Robertson, R. T., and Bokelman, D. L. (1983). Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Teratology 28, 449-456.
19. Morrissey, R. E., Lamb, J. C., Schwetz, B. A., Teague, J. L., and Morris, R. W. (1988). Association of sperm, vaginal cytology, and reproductive organ weight data with results of continuous breeding reproduction studies in Swiss (CD-1) mice. Fundam. Appl. Toxicol. 11, 359-371.
20. Nawrocki, J. W., Weiss, S. R., Davidson, M. H., Sprecher, D. L., Schwartz, S. L., Lupien, P.-J., Jones, P. H., Haber, H. E., and Black, D. M. (1995). Reductions of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler. Thromb. Vasc. Biol. 15, 678-682.
21. NIH (1985). Guide for the care and use of laboratory animals. NIH Publication 86-23.
22. Park, Y. C. (1985). Nonparametric sequential trend test. Proc. Tenth Annu. SAS Users Group Intl. Conference, 809-813.
23. Purvis, K., Tollefsrud, A., Rui, H., Haug, E., Norseth, J., Viksmoen, L., Ose, L., and Lund, H. (1992). Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia. Eur. J. Clin. Pharmacol. 42, 61-64.
24. Robaire, B., Smith, S., and Hales, B. F. (1984). Suppression of spermatogenesis by testosterone in adult male rats: Effect on fertility, pregnancy outcome and progeny. Biol. Reprod. 31, 221-230.
25. Tanase, H., and Hirose, K. (1987). Reproduction study of pravastatin sodium administered prior to and in the early stages of pregnancy in rats. Jpn. Pharmacol. Ther. 15, 4975-4982.
26. Toth, G. P., Kelty, K. C., George, E. L., Read, E. J., and Smith, M. K. (1992). Adverse male reproductive effects following subchronic exposure of rats to sodium dichloroacetate. Fundam. Appl. Toxicol. 19, 57-63.
27. Tukey, J. W., Ciminera, J. L., and Heyse, J. F. (1985). Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 42, 295-301.
28. Tsujita, Y., Kuroda, M., Shimada, Y., Tanzawa, K., Arai, M., Kaneko, I., Tanaka, M., Masuda, H., Tarumi, C., Watanabe, Y., and Fujii, S. (1986). CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: Tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim. Biophys. Acta 887, 50-60.
29. Wise, L. D., Minsker, D. H., Robertson, R. T., Bokelman, D. L., Akutsu, S., and Fujii, T. (1990). Simvastatin (MK-0733): Oral fertility study in rats. Oyo Yakuri/Pharmacometrics 39, 127-141.
30. Wyrobek, A. J., and Bruce, W. R. (1975). Chemical induction of sperm abnormalities in mice. Proc. Natl. Acad. Sci. USA 72, 4423-4429.